MKS Instruments Reports Third Quarter 2020 Financial Results
- Record quarterly consolidated revenue of
$590 million, up 28% year-over-year - Record quarterly Semiconductor Market revenue of
$359 million, up 61% year-over-year - Quarterly non-GAAP net earnings per diluted share of
$1.93 , up 72% year-over-year - Quarterly GAAP net income per diluted share of
$1.66 - Record quarterly operating cash flow of
$152 million and free cash flow of$123 million
“We delivered record quarterly revenue for MKS, led by record Semiconductor Market revenue and a recovery in our Advanced Markets revenue. Demand for our critical enabling technologies in the Semiconductor Market was broad-based across our portfolio and, in particular, for Power Solutions, which has grown more than 110% year-on-year for the first nine months of 2020 and achieved another quarter of record revenue,” said
“We achieved another increase in our non-GAAP operating margins, marking the fourth consecutive quarterly increase. This demonstrates our continued focus on driving strong operating leverage in our financial model as well as executing on our long-standing commitment to develop innovative solutions for our customers,” said
Fourth Quarter 2020 Outlook
Based on current business levels, the Company expects revenue in the fourth quarter of 2020 could be
Conference Call Details
A conference call with management will be held on
About MKS Instruments
Use of Non-GAAP Financial Results
This press release includes financial measures that are not in accordance with
Selected GAAP and Non-GAAP Financial Measures (In millions, except per share data) |
|||||||
Third Quarter 2020 Financial Results | |||||||
Q3 2020 |
Q2 2020 |
||||||
Net revenues | $ | 590 | $ | 544 | |||
GAAP Financial Measures | |||||||
Operating margin | 19.7 | % | 18.5 | % | |||
Net income | $ | 92 | $ | 74 | |||
Diluted EPS | $ | 1.66 | $ | 1.33 | |||
Non-GAAP Financial Measures | |||||||
Operating margin | 23.1 | % | 21.6 | % | |||
Net earnings | $ | 107 | $ | 89 | |||
Diluted EPS | $ | 1.93 | $ | 1.62 |
Net revenues in the third quarter of 2020 were
Net income in the third quarter of 2020 was
Net income in the third quarter of 2020 included restructuring and other costs of
Non-GAAP net earnings, which exclude special charges and credits, were
Additional Financial Information
At
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of
Company Contact:
Vice President, Investor Relations
Telephone: (978) 557-5180
Email: david.ryzhik@mksinst.com
Unaudited Consolidated Statements of Operations (In millions, except per share data) |
|||||||||||||||
Quarter Ended | Nine Months Ended | ||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | |||||||||||
Net revenues: | |||||||||||||||
Products | $ | 506.8 | $ | 386.2 | $ | 473.0 | $ | 1,441.0 | $ | 1,184.9 | |||||
Services | 83.0 | 76.3 | 71.3 | 228.8 | 215.2 | ||||||||||
Total net revenues | 589.8 | 462.5 | 544.3 | 1,669.8 | 1,400.1 | ||||||||||
Cost of revenues: | |||||||||||||||
Products | 280.7 | 216.3 | 258.0 | 794.8 | 672.2 | ||||||||||
Services | 47.1 | 41.2 | 40.0 | 127.1 | 113.8 | ||||||||||
Total cost of revenues | 327.8 | 257.5 | 298.0 | 921.9 | 786.0 | ||||||||||
Gross profit | 262.0 | 205.0 | 246.3 | 747.9 | 614.1 | ||||||||||
Research and development | 42.5 | 41.7 | 42.8 | 127.7 | 122.3 | ||||||||||
Selling, general and administrative | 87.0 | 82.1 | 86.1 | 260.3 | 247.8 | ||||||||||
Acquisition and integration costs | 0.5 | 2.1 | 0.7 | 3.4 | 35.5 | ||||||||||
Restructuring and other | 3.1 | 1.5 | 3.3 | 6.8 | 4.7 | ||||||||||
Amortization of intangible assets | 12.5 | 17.0 | 13.8 | 42.6 | 50.3 | ||||||||||
Asset impairment | — | — | — | 1.2 | — | ||||||||||
COVID-19 related net credits | — | — | (1.2 | ) | (1.2 | ) | — | ||||||||
Fees and expenses related to repricing of Term Loan | — | 0.6 | — | — | 6.5 | ||||||||||
Gain on sale of long-lived assets | — | (6.8 | ) | — | — | (6.8 | ) | ||||||||
Income from operations | 116.4 | 66.8 | 100.8 | 307.1 | 153.8 | ||||||||||
Interest income | 0.1 | 1.2 | 0.3 | 1.1 | 4.3 | ||||||||||
Interest expense | 6.6 | 13.5 | 7.2 | 22.7 | 35.3 | ||||||||||
Other expense (income), net | 1.1 | (0.9 | ) | 1.5 | 3.0 | 0.2 | |||||||||
Income before income taxes | 108.8 | 55.4 | 92.4 | 282.5 | 122.6 | ||||||||||
Provision for income taxes | 17.1 | 8.0 | 18.7 | 48.0 | 25.0 | ||||||||||
Net income | $ | 91.7 | $ | 47.4 | $ | 73.7 | $ | 234.5 | $ | 97.6 | |||||
Net income per share: | |||||||||||||||
Basic | $ | 1.66 | $ | 0.86 | $ | 1.34 | $ | 4.26 | $ | 1.79 | |||||
Diluted | $ | 1.66 | $ | 0.86 | $ | 1.33 | $ | 4.24 | $ | 1.77 | |||||
Cash dividend per common share | $ | 0.20 | $ | 0.20 | $ | 0.20 | $ | 0.60 | $ | 0.60 | |||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 55.2 | 54.9 | 55.1 | 55.1 | 54.6 | ||||||||||
Diluted | 55.4 | 55.2 | 55.3 | 55.3 | 55.0 | ||||||||||
Unaudited Consolidated Balance Sheet (In millions) |
||||||||
2020 | 2019 | |||||||
ASSETS | ||||||||
Cash and cash equivalents | $ | 493.3 | $ | 414.6 | ||||
Short-term investments | 222.4 | 109.4 | ||||||
Trade accounts receivable, net | 363.9 | 341.1 | ||||||
Inventories | 494.2 | 462.1 | ||||||
Other current assets | 95.9 | 106.3 | ||||||
Total current assets | 1,669.7 | 1,433.5 | ||||||
Property, plant and equipment, net | 267.9 | 241.9 | ||||||
Right-of-use asset | 180.1 | 64.5 | ||||||
1,062.1 | 1,058.5 | |||||||
Intangible assets, net | 523.3 | 564.6 | ||||||
Long-term investments | 6.3 | 5.8 | ||||||
Other assets | 41.5 | 47.5 | ||||||
Total assets | $ | 3,750.9 | $ | 3,416.3 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Short-term debt | $ | 12.0 | $ | 12.1 | ||||
Accounts payable | 113.4 | 88.4 | ||||||
Accrued compensation | 95.4 | 100.9 | ||||||
Income taxes payable | 18.8 | 15.4 | ||||||
Lease liability | 16.8 | 20.6 | ||||||
Deferred revenue and customer advances | 30.4 | 21.5 | ||||||
Other current liabilities | 77.5 | 58.8 | ||||||
Total current liabilities | 364.3 | 317.7 | ||||||
Long-term debt, net | 816.8 | 871.7 | ||||||
Non-current deferred taxes | 67.2 | 72.4 | ||||||
Non-current accrued compensation | 44.9 | 43.9 | ||||||
Non-current lease liability | 172.2 | 44.8 | ||||||
Other liabilities | 58.7 | 42.5 | ||||||
Total liabilities | 1,524.1 | 1,393.0 | ||||||
Stockholders' equity: | ||||||||
Common stock | 0.1 | 0.1 | ||||||
Additional paid-in capital | 861.6 | 864.3 | ||||||
Retained earnings | 1,382.7 | 1,181.2 | ||||||
Accumulated other comprehensive loss | (17.6 | ) | (22.3 | ) | ||||
Total stockholders' equity | 2,226.8 | 2,023.3 | ||||||
Total liabilities and stockholders' equity | $ | 3,750.9 | $ | 3,416.3 | ||||
Unaudited Consolidated Statements of Cash Flows (In millions) |
|||||||||||||||
Quarter Ended | Nine Months Ended | ||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | |||||||||||
Cash flows from operating activities: | |||||||||||||||
Net income | $ | 91.7 | $ | 47.4 | $ | 73.7 | $ | 234.5 | $ | 97.6 | |||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
Depreciation and amortization | 23.3 | 27.2 | 24.1 | 75.8 | 79.9 | ||||||||||
Amortization of inventory step-up adjustment to fair value | — | — | — | — | 7.6 | ||||||||||
Amortization of debt issuance costs and original issue discount | 0.5 | 3.6 | 0.5 | 2.1 | 6.5 | ||||||||||
Stock-based compensation | 7.4 | 7.4 | 6.8 | 22.7 | 42.1 | ||||||||||
Provision for excess and obsolete inventory | 6.9 | 6.5 | 6.7 | 19.8 | 18.6 | ||||||||||
Provision for doubtful accounts | — | 0.9 | — | 0.2 | 0.2 | ||||||||||
Deferred income taxes | (4.1 | ) | (6.4 | ) | 2.8 | (0.7 | ) | (9.1 | ) | ||||||
Asset impairment | — | — | — | 1.2 | — | ||||||||||
Loss (gain) on sale of long-lived asset | 1.6 | (6.8 | ) | — | 1.6 | (6.8 | ) | ||||||||
Other | (0.3 | ) | (0.5 | ) | 0.4 | — | 0.4 | ||||||||
Changes in operating assets and liabilities | 25.1 | (18.6 | ) | 24.0 | 8.8 | (69.7 | ) | ||||||||
Net cash provided by operating activities | 152.1 | 60.7 | 139.0 | 366.0 | 167.3 | ||||||||||
Cash flows (used in) provided by investing activities: | |||||||||||||||
Acquisition of business, net of cash acquired | — | — | — | — | (988.6 | ) | |||||||||
Purchases of investments | (163.7 | ) | (53.4 | ) | (164.3 | ) | (358.2 | ) | (171.3 | ) | |||||
Maturities of investments | 84.2 | 52.9 | 47.8 | 181.5 | 93.3 | ||||||||||
Sales of investments | 35.6 | 4.7 | — | 64.3 | 162.4 | ||||||||||
Proceeds from sale of assets | — | 41.2 | — | — | 41.2 | ||||||||||
Purchases of property, plant and equipment | (29.0 | ) | (16.5 | ) | (20.9 | ) | (59.9 | ) | (44.7 | ) | |||||
Net cash (used in) provided by investing activities | (72.9 | ) | 28.9 | (137.4 | ) | (172.3 | ) | (907.7 | ) | ||||||
Cash flows (used in) provided by financing activities: | |||||||||||||||
Proceeds from short and long-term borrowings | 3.4 | 1.2 | 4.6 | 20.1 | 642.2 | ||||||||||
Payments of short-term borrowings | (2.7 | ) | (2.0 | ) | (7.6 | ) | (20.2 | ) | (3.9 | ) | |||||
Payments of long-term borrowings | (2.3 | ) | (52.2 | ) | (2.2 | ) | (56.8 | ) | (103.9 | ) | |||||
Dividend payments | (11.0 | ) | (10.9 | ) | (11.0 | ) | (33.0 | ) | (32.6 | ) | |||||
Net payments related to employee stock awards | (4.5 | ) | (0.7 | ) | (0.5 | ) | (25.4 | ) | (11.8 | ) | |||||
Net cash (used in) provided by financing activities | (17.1 | ) | (64.6 | ) | (16.7 | ) | (115.3 | ) | 490.0 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 2.3 | (5.6 | ) | 2.0 | 0.3 | (7.6 | ) | ||||||||
Increase (decrease) in cash and cash equivalents | 64.4 | 19.4 | (13.1 | ) | 78.7 | (258.0 | ) | ||||||||
Cash and cash equivalents at beginning of period | 428.9 | 366.9 | 442.0 | 414.6 | 644.3 | ||||||||||
Cash and cash equivalents at end of period | $ | 493.3 | $ | 386.3 | $ | 428.9 | $ | 493.3 | $ | 386.3 | |||||
The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS’ operating results:
Schedule Reconciling Selected Non-GAAP Financial Measures (In millions, except per share data) |
|||||||||||||||
Quarter Ended | Nine Months Ended | ||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | |||||||||||
Net income | $ | 91.7 | $ | 47.4 | $ | 73.7 | $ | 234.5 | $ | 97.6 | |||||
COVID-19 related net credits (Note 1) | — | — | (0.9 | ) | (0.9 | ) | — | ||||||||
Acquisition inventory step-up (Note 2) | — | — | — | — | 7.6 | ||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | 3.9 | — | ||||||||||
Acquisition and integration costs (Note 4) | 0.5 | 2.1 | 0.7 | 3.4 | 35.5 | ||||||||||
Amortization of debt issuance costs (Note 5) | 0.2 | 3.1 | 0.2 | 1.3 | 4.9 | ||||||||||
Restructuring and other (Note 6) | 3.1 | 1.5 | 3.3 | 6.8 | 4.7 | ||||||||||
Amortization of intangible assets | 12.5 | 17.0 | 13.8 | 42.6 | 50.3 | ||||||||||
Asset impairment (Note 7) | — | — | — | 1.2 | — | ||||||||||
Fees and expenses related to repricing of Term Loan (Note 8) | — | 0.6 | — | — | 6.5 | ||||||||||
Gain on sale of long-lived assets (Note 9) | — | (6.8 | ) | — | — | (6.8 | ) | ||||||||
Windfall tax benefit on stock-based compensation (Note 10) | (0.2 | ) | 0.3 | (1.4 | ) | (2.4 | ) | (1.9 | ) | ||||||
Deferred tax asset write-off (Note 11) | — | — | 3.5 | 3.5 | — | ||||||||||
Tax reform adjustments (Note 12) | — | 0.1 | — | — | 2.8 | ||||||||||
Tax effect of Non-GAAP adjustments (Note 19) | (4.7 | ) | (3.7 | ) | (3.6 | ) | (12.7 | ) | (18.5 | ) | |||||
Non-GAAP net earnings (Note 13) | $ | 107.0 | $ | 61.6 | $ | 89.3 | $ | 281.2 | $ | 182.7 | |||||
Non-GAAP net earnings per diluted share (Note 13) | $ | 1.93 | $ | 1.12 | $ | 1.62 | $ | 5.08 | $ | 3.32 | |||||
Weighted average diluted shares outstanding | 55.4 | 55.2 | 55.3 | 55.3 | 55.0 | ||||||||||
Net cash provided by operating activities | $ | 152.1 | $ | 60.7 | $ | 139.0 | $ | 366.0 | $ | 167.3 | |||||
Purchases of property, plant and equipment | (29.0 | ) | (16.5 | ) | (20.9 | ) | (59.9 | ) | (44.7 | ) | |||||
Free cash flow | $ | 123.1 | $ | 44.2 | $ | 118.1 | $ | 306.1 | $ | 122.6 | |||||
Schedule Reconciling Selected Non-GAAP Financial Measures (In millions) |
|||||||||||||||
Quarter Ended | Nine Months Ended | ||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | |||||||||||
Gross profit | $ | 262.0 | $ | 205.0 | $ | 246.3 | $ | 747.9 | $ | 614.1 | |||||
COVID-19 related net costs (Note 1) | — | — | 0.3 | 0.3 | — | ||||||||||
Acquisition inventory step-up (Note 2) | — | — | — | — | 7.6 | ||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | 3.9 | — | ||||||||||
Non-GAAP gross profit (Note 14) | $ | 265.9 | $ | 205.0 | $ | 246.6 | $ | 752.1 | $ | 621.7 | |||||
Non-GAAP gross margin (Note 14) | 45.1 | % | 44.3 | % | 45.3 | % | 45.0 | % | 44.4 | % | |||||
Operating expenses | $ | 145.6 | $ | 138.2 | $ | 145.5 | $ | 440.8 | $ | 460.3 | |||||
Acquisition and integration costs (Note 4) | 0.5 | 2.1 | 0.7 | 3.4 | 35.5 | ||||||||||
Restructuring and other (Note 6) | 3.1 | 1.5 | 3.3 | 6.8 | 4.7 | ||||||||||
Amortization of intangible assets | 12.5 | 17.0 | 13.8 | 42.6 | 50.3 | ||||||||||
Asset impairment (Note 7) | — | — | — | 1.2 | — | ||||||||||
COVID-19 related net credits (Note 1) | — | — | (1.2 | ) | (1.2 | ) | — | ||||||||
Fees and expenses related to repricing of Term Loan (Note 8) | — | 0.6 | — | — | 6.5 | ||||||||||
Gain on sale of long-lived assets (Note 9) | — | (6.8 | ) | — | — | (6.8 | ) | ||||||||
Non-GAAP operating expenses (Note 15) | $ | 129.5 | $ | 123.8 | $ | 128.9 | $ | 388.0 | $ | 370.1 | |||||
Income from operations | $ | 116.4 | $ | 66.8 | $ | 100.8 | $ | 307.1 | $ | 153.8 | |||||
COVID-19 related net credits (Note 1) | — | — | (0.9 | ) | (0.9 | ) | — | ||||||||
Acquisition inventory step-up (Note 2) | — | — | — | — | 7.6 | ||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | 3.9 | — | ||||||||||
Acquisition and integration costs (Note 4) | 0.5 | 2.1 | 0.7 | 3.4 | 35.5 | ||||||||||
Restructuring and other (Note 6) | 3.1 | 1.5 | 3.3 | 6.8 | 4.7 | ||||||||||
Amortization of intangible assets | 12.5 | 17.0 | 13.8 | 42.6 | 50.3 | ||||||||||
Asset impairment (Note 7) | — | — | — | 1.2 | — | ||||||||||
Fees and expenses related to repricing of Term Loan (Note 8) | — | 0.6 | — | — | 6.5 | ||||||||||
Gain on sale of long-lived assets (Note 9) | — | (6.8 | ) | — | — | (6.8 | ) | ||||||||
Non-GAAP income from operations (Note 16) | $ | 136.4 | $ | 81.2 | $ | 117.7 | $ | 364.1 | $ | 251.6 | |||||
Non-GAAP operating margin (Note 16) | 23.1 | % | 17.6 | % | 21.6 | % | 21.8 | % | 18.0 | % | |||||
Interest expense, net | $ | 6.5 | $ | 12.3 | $ | 6.9 | $ | 21.6 | $ | 31.0 | |||||
Amortization of debt issuance costs (Note 5) | 0.2 | 3.1 | 0.2 | 1.3 | 4.9 | ||||||||||
Non-GAAP interest expense, net | $ | 6.3 | $ | 9.2 | $ | 6.7 | $ | 20.3 | $ | 26.1 | |||||
Net income | $ | 91.7 | $ | 47.4 | $ | 73.7 | $ | 234.5 | $ | 97.6 | |||||
Interest expense, net | 6.5 | 12.3 | 6.9 | 21.6 | 31.0 | ||||||||||
Provision for income taxes | 17.1 | 8.0 | 18.7 | 48.0 | 25.0 | ||||||||||
Depreciation | 10.9 | 10.2 | 10.3 | 33.3 | 29.6 | ||||||||||
Amortization of intangible assets | 12.5 | 17.0 | 13.8 | 42.6 | 50.3 | ||||||||||
EBITDA (Note 17) | $ | 138.7 | $ | 94.9 | $ | 123.4 | $ | 380.0 | $ | 233.5 | |||||
Stock-based compensation | 7.3 | 5.8 | 6.7 | 22.0 | 20.9 | ||||||||||
COVID-19 related net credits (Note 1) | — | — | (0.9 | ) | (0.9 | ) | — | ||||||||
Acquisition inventory step-up (Note 2) | — | — | — | — | 7.6 | ||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | 3.9 | — | ||||||||||
Acquisition and integration costs (Note 4) | 0.5 | 2.1 | 0.7 | 3.4 | 35.5 | ||||||||||
Restructuring and other (Note 6) | 3.1 | 1.5 | 3.3 | 6.8 | 4.7 | ||||||||||
Asset impairment (Note 7) | — | — | — | 1.2 | — | ||||||||||
Fees and expenses related to repricing of Term Loan (Note 8) | — | 0.6 | — | — | 6.5 | ||||||||||
Gain on sale of long-lived assets (Note 9) | — | (6.8 | ) | — | — | (6.8 | ) | ||||||||
Other adjustments | — | — | — | — | 3.4 | ||||||||||
Adjusted EBITDA (Note 18) | $ | 153.5 | $ | 98.1 | $ | 133.2 | $ | 416.4 | $ | 305.3 | |||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate (In millions) |
|||||||||||||||||||||||
Three Months Ended |
Three Months Ended |
||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | ||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | ||||||||||||||||||
GAAP | $ | 108.8 | $ | 17.1 | 15.7 | % | $ | 55.4 | $ | 8.0 | 14.4 | % | |||||||||||
Adjustments: | |||||||||||||||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | — | |||||||||||||||||||
Acquisition and integration costs (Note 4) | 0.5 | — | 2.1 | — | |||||||||||||||||||
Amortization of debt issuance costs (Note 5) | 0.2 | — | 3.1 | — | |||||||||||||||||||
Restructuring and other (Note 6) | 3.1 | — | 1.5 | — | |||||||||||||||||||
Amortization of intangible assets | 12.5 | — | 17.0 | — | |||||||||||||||||||
Fees and expenses related to Term Loan (Note 8) | — | — | 0.6 | — | |||||||||||||||||||
Gain on sale of long-lived assets (Note 9) | — | — | (6.8 | ) | — | ||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 10) | — | 0.2 | — | (0.3 | ) | ||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 19) | — | 4.7 | — | 3.7 | |||||||||||||||||||
Non-GAAP | $ | 129.0 | $ | 22.0 | 17.0 | % | $ | 72.9 | $ | 11.4 | 15.6 | % | |||||||||||
Three Months Ended |
|||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | |||||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | |||||||||||||||||||||
GAAP | $ | 92.4 | $ | 18.7 | 20.2 | % | |||||||||||||||||
Adjustments: | |||||||||||||||||||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | ||||||||||||||||||||
Acquisition and integration costs (Note 4) | 0.7 | — | |||||||||||||||||||||
Amortization of debt issuance costs (Note 5) | 0.2 | — | |||||||||||||||||||||
Restructuring and other (Note 6) | 3.3 | — | |||||||||||||||||||||
Amortization of intangible assets | 13.8 | — | |||||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 10) | — | 1.4 | |||||||||||||||||||||
Deferred tax asset write-off (Note 10) | — | (3.5 | ) | ||||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 19) | — | 3.6 | |||||||||||||||||||||
Non-GAAP | $ | 109.5 | $ | 20.2 | 18.5 | % | |||||||||||||||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate (In millions) |
|||||||||||||||||||||||
Nine Months Ended |
Nine Months Ended |
||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | ||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | ||||||||||||||||||
GAAP | $ | 282.5 | $ | 48.0 | 17.0 | % | $ | 122.6 | $ | 25.0 | 20.4 | % | |||||||||||
Adjustments: | |||||||||||||||||||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | — | ||||||||||||||||||
Acquisition inventory step-up (Note 2) | — | — | 7.6 | ||||||||||||||||||||
Inventory charge related to exit of product groups (Note 3) | 3.9 | — | — | — | |||||||||||||||||||
Acquisition and integration costs (Note 4) | 3.4 | — | 35.5 | — | |||||||||||||||||||
Amortization of debt issuance costs (Note 5) | 1.3 | — | 4.9 | — | |||||||||||||||||||
Restructuring and other (Note 6) | 6.8 | — | 4.7 | — | |||||||||||||||||||
Amortization of intangible assets | 42.6 | — | 50.3 | — | |||||||||||||||||||
Asset impairment (Note 6) | 1.2 | — | — | — | |||||||||||||||||||
Fees and expenses related to Term Loan (Note 8) | — | — | 6.5 | — | |||||||||||||||||||
Gain on sale of long-lived assets (Note 9) | (6.8 | ) | |||||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 10) | — | 2.4 | — | 1.9 | |||||||||||||||||||
Deferred tax asset write-off (Note 11) | — | (3.5 | ) | — | — | ||||||||||||||||||
Tax reform adjustments (Note 12) | — | — | — | (2.8 | ) | ||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 19) | — | 12.7 | — | 18.5 | |||||||||||||||||||
Non-GAAP | $ | 340.8 | $ | 59.6 | 17.5 | % | $ | 225.3 | $ | 42.6 | 18.9 | % | |||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures – Q4’20 Guidance (In millions, except per share data) |
|||||||||||||||||||||||
Three Months Ending |
|||||||||||||||||||||||
$ Amount | Plus or Minus |
Per Share | Plus or Minus |
||||||||||||||||||||
GAAP net income | $ | 97.1 | $ | 11.1 | $ | 1.75 | $ | 0.20 | |||||||||||||||
Amortization of intangible assets | 12.6 | — | 0.23 | — | |||||||||||||||||||
Deferred financing costs | 0.2 | — | — | — | |||||||||||||||||||
Acquisition and integration costs | 0.5 | — | 0.01 | — | |||||||||||||||||||
Restructuring and other costs | 3.5 | — | 0.06 | — | |||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 19) | (2.9 | ) | — | (0.05 | ) | — | |||||||||||||||||
Non-GAAP net earnings | $ | 111.0 | $ | 11.1 | $ | 2.00 | $ | 0.20 | |||||||||||||||
Estimated weighted average diluted shares | 55.4 | ||||||||||||||||||||||
Three Months Ending |
|||||||||||||||||||||||
$ Amount | Plus or Minus |
||||||||||||||||||||||
GAAP operating expenses | $ | 149.6 | $ | 4.0 | |||||||||||||||||||
Acquisition and integration costs | (0.5 | ) | — | ||||||||||||||||||||
Restructuring and other costs | (3.5 | ) | — | ||||||||||||||||||||
Amortization of intangible assets | (12.6 | ) | — | ||||||||||||||||||||
Non-GAAP operating expenses | $ | 133.0 | $ | 4.0 | |||||||||||||||||||
Three Months Ending |
|||||||||||||||||||||||
$ Amount | Plus or Minus |
Percentage | Plus or Minus |
||||||||||||||||||||
GAAP operating income and margin | $ | 123.3 | $ | 13.3 | 20.5 | % | 1.3 | % | |||||||||||||||
Acquisition and integration costs | 0.5 | — | 0.1 | — | |||||||||||||||||||
Restructuring and other costs | 3.5 | — | 0.6 | — | |||||||||||||||||||
Amortization of intangible assets | 12.6 | — | 2.1 | — | |||||||||||||||||||
Non-GAAP operating income and margin | $ | 139.9 | $ | 13.3 | 23.3 | % | 1.3 | % | |||||||||||||||
Three Months Ending |
|||||||||||||||||||||||
Guidance | |||||||||||||||||||||||
$ Amount | |||||||||||||||||||||||
GAAP interest expense, net | $ | 6.2 | |||||||||||||||||||||
Deferred financing costs | (0.2 | ) | |||||||||||||||||||||
Non-GAAP interest expense, net | $ | 6.0 | |||||||||||||||||||||
Notes on Our Non-GAAP Financial Information
Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS' reported GAAP results, and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.
Note 1: During the nine months ended
Note 2: Cost of revenues during the nine months ended
Note 3: During the three and nine months ended
Note 4: Acquisition and integration costs were primarily related to the ESI Acquisition which closed on
Note 5: We recorded additional interest expense related to the amortization of debt issuance costs related to our Term Loan Credit Agreement and our ABL Credit Agreement.
Note 6: Restructuring and other costs during the three and nine months ended
Note 7: During the nine months ended
Note 8: We recorded fees and expenses during the three months ended
Note 9: During the three and nine months ended
Note 10: We recorded windfall tax benefits on the vesting of stock-based compensation.
Note 11: We recorded a write-off of a deferred tax asset related to foreign net operating losses.
Note 12: We recorded tax adjustments during the three and nine months ended
Note 13: Non-GAAP net earnings and Non-GAAP net earnings per diluted share amounts exclude net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, an inventory charge related to the exit of certain product groups, acquisition and integration costs, amortization of debt issuance costs, restructuring and other costs, amortization of intangible assets, asset impairments, fees and expenses related to repricings of, and amendments to, our Term Loan Credit Agreement, gain on the sale of long-lived assets, windfall tax adjustments related to stock compensation expense, a deferred tax write-off, tax reform adjustments and the related tax effect of these adjustments to reflect the expected full year effective tax rate in the related period.
Note 14: The Non-GAAP gross profit amount and Non-GAAP gross margin percentages exclude net costs related to the COVID-19 pandemic, an inventory charge related to the exit of certain product groups and the amortization of the step-up of inventory to fair value.
Note 15: Non-GAAP operating expenses exclude acquisition and integration costs, restructuring and other costs, amortization of intangible assets, an asset impairment, net credits related to the COVID-19 pandemic, fees and expenses related to repricings of our Term Loan Credit Agreement and a gain on the sale of long-lived assets.
Note 16: Non-GAAP income from operations and Non-GAAP operating margin percentages exclude net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, an inventory charge related to the exit of certain product groups, acquisition and integration costs, restructuring and other costs, amortization of intangible assets, an asset impairment, fees and expenses related to repricings of our Term Loan Credit Agreement and a gain on the sale of long-lived assets.
Note 17: EBITDA excludes net interest, income taxes, depreciation and amortization of intangible assets.
Note 18: Adjusted EBITDA excludes from EBITDA, stock-based compensation, net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, an inventory charge related to the exit of certain product groups, acquisition and integration costs, restructuring and other costs, an asset impairment, fees and expenses related to repricings and amendments of our Term Loan Credit Agreement and a gain on the sale of long-lived assets.
Note 19: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates. For the three months ending
Source: MKS Instruments, Inc.